Home › Research › How common it is
Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study
Blass B, Ford CB, Soneji S, Zepel L, Rosa TD, Kaufman BG, Mantri S, Li F, Mac Grory B, Xian Y, et al.. BMJ, 2025-05-20
Topic: Risk, prevention and care in population studies
Plain-language summary
Objective To determine the incidence and prevalence of dementia in a nationally representative cohort of US Medicare beneficiaries, stratified by important subgroups. Design Population based study. Setting Nationwide study between 2015 and 2021. Participants Fee-for-service Medicare beneficiaries aged 66 or older with at least one year of continuous enrollment. Main outcome measures Incidence and prevalence of dementia, calculated as percentage per person years or percentage of beneficiaries respectively. These metrics were also calculated in key subgroups defined by age, sex, race/ethnicity, and neighborhood socioeconomic status. Results A total of 5 025 039 incident cases of dementia were documented from 2015 to 2021. The overall age and sex standardized incidence decreased between 2015 and 2021 from 3.5% to 2.8%. Prevalence increased during this time from 10.5% to 11.8%. Male beneficiaries had a higher age standardized incidence than did female beneficiaries in 2015 (3.5% v 3.4%), a difference that widened by 2021 (2.9% v 2.6%; estimated difference-in-difference 0.94, 95% confidence interval (CI) 0.94 to 0.95; P Conclusions The incidence of dementia decreased from 2015 to 2021, but the prevalence increased. Disparities in these measures by race/ethnicity, sex, and neighborhood socioeconomic status should motivate future measures to promote health equity.
What this study adds
Evidence grade: High
This is a follow-up (cohort) study. Among US Medicare beneficiaries, the rate of new dementia cases fell from 3.5% to 2.8% between 2015 and 2021, while the total share of beneficiaries living with dementia rose from 10.5% to 11.8%. Reported effect size: Incidence 3.5% (2015) to 2.8% (2021) per year; prevalence 10.5% to 11.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Blass, B., Ford, C. B., Soneji, S., Zepel, L., Rosa, T. D., Kaufman, B. G., et al. (2025). Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study. BMJ. https://doi.org/10.1136/bmj-2024-083034
Vancouver
Blass B, Ford CB, Soneji S, Zepel L, Rosa TD, Kaufman BG, et al. Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study. BMJ. 2025. doi:10.1136/bmj-2024-083034. PMID: 40393738.
BibTeX
@article{blass2025-40393738,
author = {Blass, B. and Ford, C. B. and Soneji, S. and Zepel, L. and Rosa, T. D. and Kaufman, B. G. and Mantri, S. and Li, F. and Mac Grory, B. and Xian, Y. and others},
title = {{Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study}},
journal = {BMJ},
year = {2025},
doi = {10.1136/bmj-2024-083034},
pmid = {40393738},
url = {https://doi.org/10.1136/bmj-2024-083034}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results A total of 5 025 039 incident cases of dementia were documented from 2015 to 2021.
- The overall age and sex standardized incidence decreased between 2015 and 2021 from 3.5% to 2.8%.
Why it matters
Among US Medicare beneficiaries, the rate of new dementia cases fell from 3.5% to 2.8% between 2015 and 2021, while the total share of beneficiaries living with dementia rose from 10.5% to 11.8%. The authors say disparities by race/ethnicity, sex, and neighborhood socioeconomic status should motivate future measures to promote health equity.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designcohort
- Effect sizeIncidence 3.5% (2015) to 2.8% (2021) per year; prevalence 10.5% to 11.8%
- Evidence strengthHigh
Limitations
Claims-based diagnoses miss undiagnosed dementia; excludes Medicare Advantage enrollees (a growing share); part of the incidence decline may reflect pandemic-era reductions in healthcare contact.
How this study scored 61/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 60 of the 98 points we could judge it on, which is 61 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (BMJ) |
| Journal's citation record | 3 / 4 | BMJ: journal h-index 413 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 22 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 14.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 22 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Jay B. Lusk: h-index 24 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of North Carolina at Chapel Hill: institution h-index 1,674 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40393738) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 60 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 60 of the 98 points we could judge it on is 61 out of 100. |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in How common it is from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.